Inventor

FISHMAN PNINA

IL22 patents

⚠️ This page may combine multiple inventors who share the name “FISHMAN PNINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FISHMAN PNINA

CAN FITE BIOPHARMA LTD

Use of an adenosine A3 receptor agonist for inhibition of viral replication

Pharmaceutical administration of adenosine agonists

Method for inducing hepatocyte proliferation and uses thereof

Treatment of dry eye conditions

Use of A3 adenosine receptor agonist in osteoarthritis treatment

Method of treating leukopenia with adenosine

Pharmaceutical administration of adenosine agonists

Method for treating fibrotic liver tissue using Cl-IB-MECA

Method for treatment of multiple sclerosis

A3 adenosine receptor ligand for use for achieving a fat loss effect

Compositions containing muscle-derived active agents

Method for treating NASH accompanied by fibrosis using Cl-IB-MECA

FISHMAN PNINA

Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

Method for inducing hepatocyte proliferation and uses thereof

Biological marker for inflammation

A3 adenoside receptor agonists for the reduction of intraocular pressure

CAN FITE BIOPHARMA LTD ISRAEL

A3AR agonists for the treatment of inflammatory arthritis

ARP BIOMED INC

Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin

ARP BIOMED LTD

Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins

UNIV BAR ILAN

Anti-metastatic factor

CAN-FITE BIOPHARMA LTD

A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

CAN FITE TECHNOLOGIES LTD

Cell growth regulator